News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,966 Results
Type
Article (76460)
Company Profile (718)
Press Release (771756)
Multimedia
Podcasts (215)
Webinars (34)
Section
Business (228309)
Career Advice (3749)
Deals (39531)
Drug Delivery (172)
Drug Development (89974)
Employer Resources (207)
FDA (18254)
Job Trends (17266)
News (389829)
Policy (39047)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (1)
Accelerated approval (48)
Adcomms (37)
Allergies (181)
Alliances (56144)
ALS (214)
Alzheimer's disease (1907)
Antibody-drug conjugate (ADC) (480)
Approvals (18526)
Artificial intelligence (729)
Autoimmune disease (280)
Automation (56)
Bankruptcy (405)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (233)
Biotechnology (443)
Bladder cancer (191)
Brain cancer (78)
Breast cancer (756)
Cancer (5974)
Cardiovascular disease (514)
Career advice (3222)
Career pathing (48)
CAR-T (347)
CDC (73)
Celiac Disease (2)
Cell therapy (941)
Cervical cancer (47)
Clinical research (76986)
Collaboration (2208)
Company closure (6)
Compensation (1372)
Complete response letters (100)
COVID-19 (3021)
CRISPR (115)
C-suite (1142)
Cystic fibrosis (162)
Data (7715)
Decentralized trials (3)
Denatured (80)
Depression (182)
Dermatology (74)
Diabetes (610)
Diagnostics (7465)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (352)
Drug pricing (240)
Drug shortages (39)
Duchenne muscular dystrophy (293)
Earnings (98812)
Editorial (75)
Employer branding (25)
Employer resources (174)
Events (135978)
Executive appointments (1139)
FDA (22005)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1795)
Gene editing (252)
Generative AI (73)
Gene therapy (777)
GLP-1 (1227)
Government (5479)
Grass and pollen (8)
Guidances (408)
Healthcare (21043)
HIV (85)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (336)
Immuno-oncology (98)
Indications (173)
Infectious disease (3387)
Inflammatory bowel disease (227)
Inflation Reduction Act (17)
Influenza (145)
Intellectual property (288)
Interviews (732)
IPO (17907)
IRA (61)
Job creations (5006)
Job search strategy (2602)
JPM (73)
Kidney cancer (20)
Labor market (109)
Layoffs (668)
Leadership (48)
Legal (9971)
Liver cancer (107)
Longevity (32)
Lung cancer (799)
Lymphoma (431)
Machine learning (61)
Management (66)
Manufacturing (1074)
MASH (197)
Medical device (15171)
Medtech (15265)
Mergers & acquisitions (22841)
Metabolic disorders (1638)
mRNA (235)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (447)
Neuropsychiatric disorders (121)
Neuroscience (3501)
Neurotech (1)
NextGen: Class of 2026 (7662)
Non-profit (5129)
Now hiring (76)
Obesity (799)
Opinion (364)
Ovarian cancer (213)
Pain (264)
Pancreatic cancer (300)
Parkinson's disease (379)
Partnered (36)
Patents (599)
Patient recruitment (663)
Peanut (66)
People (66380)
Pharmaceutical (128)
Pharmacy benefit managers (36)
Phase 1 (23825)
Phase 2 (33579)
Phase 3 (25279)
Pipeline (8034)
Policy (378)
Postmarket research (3261)
Preclinical (10506)
Press Release (72)
Prostate cancer (301)
Psychedelics (65)
Radiopharmaceuticals (348)
Rare diseases (1154)
Real estate (7217)
Recruiting (81)
Regulatory (29208)
Reports (74)
Research institute (2754)
Resumes & cover letters (583)
Rett syndrome (37)
RNA editing (26)
RSV (98)
Schizophrenia (187)
Series A (304)
Series B (221)
Service/supplier (26)
Sickle cell disease (119)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (54)
Startups (4262)
State (2)
Stomach cancer (21)
Supply chain (137)
Tariffs (104)
The Weekly (132)
Vaccines (1249)
Venture capital (116)
Weight loss (552)
Women's health (125)
Worklife (24)
Date
Today (202)
Last 7 days (758)
Last 30 days (2995)
Last 365 days (32718)
2026 (10913)
2025 (32543)
2024 (37887)
2023 (42566)
2022 (53927)
2021 (58722)
2020 (57662)
2019 (51301)
2018 (39083)
2017 (36841)
2016 (37746)
2015 (43739)
2014 (38419)
2013 (34395)
2012 (36293)
2011 (36411)
2010 (35841)
Location
Africa (1215)
Alabama (100)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (50597)
Australia (8675)
California (13250)
Canada (3736)
China (1401)
Colorado (573)
Connecticut (583)
Delaware (402)
Europe (114691)
Florida (1968)
Georgia (434)
Hawaii (4)
Idaho (68)
Illinois (1118)
India (96)
Indiana (621)
Iowa (25)
Japan (533)
Kansas (137)
Kentucky (54)
Louisiana (45)
Maine (87)
Maryland (1620)
Massachusetts (9668)
Michigan (390)
Minnesota (743)
Mississippi (7)
Missouri (160)
Montana (37)
Nebraska (30)
Nevada (145)
New Hampshire (91)
New Jersey (3553)
New Mexico (33)
New York (3500)
North Carolina (1793)
North Dakota (10)
Northern California (6513)
Ohio (406)
Oklahoma (26)
Oregon (53)
Pennsylvania (2640)
Puerto Rico (29)
Rhode Island (53)
South America (1580)
South Carolina (87)
South Dakota (2)
Southern California (5175)
Tennessee (211)
Texas (2119)
United States (47496)
Utah (395)
Vermont (1)
Virginia (337)
Washington D.C. (88)
Washington State (1094)
West Virginia (4)
Wisconsin (148)
Wyoming (2)
848,966 Results for "shanghai hengrui pharmaceuticals co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
April 22, 2026
·
1 min read
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
February 10, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Hengrui Pharma Announces Strong 2025 Annual Results
March 26, 2026
·
2 min read
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
Hengrui Pharmaceuticals has been busy this year, signing a nearly $2 billion cardio contract with Merck in March and a 12-asset agreement with GSK in July worth up to $12 billion.
September 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
Press Releases
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
April 21, 2026
·
4 min read
Deals
GSK Bets Up To $12B for Multi-Program Cancer Pact With Hengrui
The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline that’s anchored by the anti-asthma drug Nucala.
July 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
April 9, 2026
·
2 min read
Press Releases
Kailera Therapeutics and Hengrui Pharma Report Positive Topline Data from Phase 2 Obesity Trial of Oral Ribupatide
February 10, 2026
·
8 min read
Press Releases
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
January 12, 2026
·
5 min read
1 of 84,897
Next
